Compounds for treatment of eye diseases
US-2023044608-A1 · Feb 9, 2023 · US
This page is not indexed by search engines while we improve data quality.
Nykjaer Anders patents
Nykjaer Anders is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Nykjaer Anders |
| Total patents | 21 |
| First publication | Jan 22, 2015 |
| Latest publication | Feb 9, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
SorCS1 for the treatment of obesity
US-10172918-B2 · Jan 8, 2019 · US
SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
US-9931374-B2 · Apr 3, 2018 · US
Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular Disease
US-2017318057-A1 · Nov 2, 2017 · US
Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders
US-2017240611-A1 · Aug 24, 2017 · US
Modulation of Activity of Neurotrophins
US-2017158766-A1 · Jun 8, 2017 · US
Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
US-9670263-B2 · Jun 6, 2017 · US
Modulation of activity of neurotrophins
US-9605073-B2 · Mar 28, 2017 · US
SorCS1 for the Treatment of Obesity
US-2017014476-A1 · Jan 19, 2017 · US
Use of Sortilin as Biomarker for Affective/Mood Disorders
US-2016349276-A1 · Dec 1, 2016 · US
Recent patents
Latest publications not already listed above.
SorCS1 for the treatment of obesity
US-9387232-B2 · Jul 12, 2016 · US
Modulation of Activity of Proneurotrophins
US-2016060346-A1 · Mar 3, 2016 · US
SorCS1-Like Agent for Use in the Treatment of Insulin Resistance and Diseases Related Thereto
US-2016015778-A1 · Jan 21, 2016 · US
Modulation of activity of proneurotrophins
US-9234036-B2 · Jan 12, 2016 · US
Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular Disease
US-2015299304-A1 · Oct 22, 2015 · US
Modulation of the Interaction Between SorLA and GDNF-Family Ligand Receptors
US-2015239973-A1 · Aug 27, 2015 · US
Modulation of Activity of Neurotrophins
US-2015232565-A1 · Aug 20, 2015 · US
SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
US-9101117-B2 · Aug 11, 2015 · US
SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT
US-2015166629-A1 · Jun 18, 2015 · US
Modulation of activity of neurotrophins
US-8986690-B2 · Mar 24, 2015 · US
Modulation of Activity of Proneurotrophins
US-2015023971-A1 · Jan 22, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Lundbeck & Co As H | 8 |
| Univ Aarhus | 8 |
| H Lundbeck As | 6 |
| Nykjaer Anders | 4 |
| Pedersen Karen-Marie | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K38/00 | 15 |
| A61K38/177 | 13 |
| A61P25/00 | 10 |
| C07K2317/76 | 10 |
| C07K16/286 | 9 |